North America Non-Vascular Stents Market Outlook to 2036 – Airway Stents, Enteral Stents and Pancreatic and Biliary Stents

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: June 30, 2026 Report Code: GDME22101CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Non-Vascular Stents Market Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Non-Vascular Stents market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Airway Stents, Enteral Stents, Pancreatic and Biliary Stents

The North America Non-Vascular Stents Market report provides key information and data on –
– Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
– 2023 company share data for Non-Vascular Stents Market.
– Global corporate-level profiles of key companies operating within the North America Non-Vascular Stents Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Non-Vascular Stents is segmented as follows:

– Dental Implants

– Dental Abutments

Reasons to Buy

The North America Non-Vascular Stents Market report helps you to develop:

– Business strategies by identifying the key market segments poised for strong growth in the future.

– Market-entry and market expansion strategies.

– Design competition strategies by identifying who-stands-where in the market.

– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Boston Scientific Corp
Atrium Medical Corp
Medtronic Plc
Merit Medical Systems Inc
Wilson-Cook Medical Inc
Cordis Corp
W. L. Gore & Associates Inc
MITech Co Ltd
CR Bard Inc
CONMED Corp

Table of Contents_x000D_

List of Tables_x000D_

List of Figures_x000D_

1 Introduction_x000D_

1.1 What Is This Report About?_x000D_

1.2 Non-Vascular Stents Market Segmentation_x000D_

1.3 Definitions of Markets Covered in the Report_x000D_

2 Non-Vascular Stents Market, North America_x000D_

2.1 Non-Vascular Stents Market, North America, Revenue ($m), 2024-2036_x000D_

2.2 Non-Vascular Stents Market, North America, Revenue ($m), 2024-2036_x000D_

2.3 Non-Vascular Stents Market, North America, Volume (Units), 2024-2036_x000D_

2.4 Non-Vascular Stents Market, North America, Volume (Units), 2024-2036_x000D_

2.5 Non-Vascular Stents Market, North America, Company Share by Revenue ($m), 2025_x000D_

3 Non-Vascular Stents Market, Canada_x000D_

3.1 Non-Vascular Stents Market, Canada, Revenue ($m), 2024-2036_x000D_

3.1.1 Airway Stents Market, Canada, Revenue ($m), by Segment, 2024-2036_x000D_

3.1.2 Enteral Stents Market, Canada, Revenue ($m), by Segment, 2024-2036_x000D_

3.1.3 Pancreatic and Biliary Stents Market, Canada, Revenue ($m), by Segment, 2024-2036_x000D_

3.2 Non-Vascular Stents Market, Canada, Volume (Units), 2024-2036_x000D_

3.2.1 Airway Stents Market, Canada, Volume (Units), by Segment, 2024-2036_x000D_

3.2.2 Enteral Stents Market, Canada, Volume (Units), by Segment, 2024-2036_x000D_

3.2.3 Pancreatic and Biliary Stents Market, Canada, Volume (Units), by Segment, 2024-2036_x000D_

3.3 Non-Vascular Stents Market, Canada, Average Price ($), 2024-2036_x000D_

3.4 Non-Vascular Stents Market, Canada, Company Share by Revenue ($m), 2025_x000D_

4 Non-Vascular Stents Market, Mexico_x000D_

4.1 Non-Vascular Stents Market, Mexico, Revenue ($m), 2024-2036_x000D_

4.1.1 Airway Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036_x000D_

4.1.2 Enteral Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036_x000D_

4.1.3 Pancreatic and Biliary Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036_x000D_

4.2 Non-Vascular Stents Market, Mexico, Volume (Units), 2024-2036_x000D_

4.2.1 Airway Stents Market, Mexico, Volume (Units), by Segment, 2024-2036_x000D_

4.2.2 Enteral Stents Market, Mexico, Volume (Units), by Segment, 2024-2036_x000D_

4.2.3 Pancreatic and Biliary Stents Market, Mexico, Volume (Units), by Segment, 2024-2036_x000D_

4.3 Non-Vascular Stents Market, Mexico, Average Price ($), 2024-2036_x000D_

4.4 Non-Vascular Stents Market, Mexico, Company Share by Revenue ($m), 2025_x000D_

5 Non-Vascular Stents Market, United States_x000D_

5.1 Non-Vascular Stents Market, United States, Revenue ($m), 2024-2036_x000D_

5.1.1 Airway Stents Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_

5.1.2 Enteral Stents Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_

5.1.3 Pancreatic and Biliary Stents Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_

5.2 Non-Vascular Stents Market, United States, Volume (Units), 2024-2036_x000D_

5.2.1 Airway Stents Market, United States, Volume (Units), by Segment, 2024-2036_x000D_

5.2.2 Enteral Stents Market, United States, Volume (Units), by Segment, 2024-2036_x000D_

5.2.3 Pancreatic and Biliary Stents Market, United States, Volume (Units), by Segment, 2024-2036_x000D_

5.3 Non-Vascular Stents Market, United States, Average Price ($), 2024-2036_x000D_

5.4 Non-Vascular Stents Market, United States, Company Share by Revenue ($m), 2025_x000D_

6 Non-Vascular Stents Market Pipeline Products_x000D_

6.1 Non-Vascular Stents Market Pipeline Products_x000D_

6.2 Non-Vascular Stents – Pipeline Products by Stage of Development_x000D_

6.3 Non-Vascular Stents – Pipeline Products by Segment_x000D_

6.4 Non-Vascular Stents – Pipeline Products by Territory_x000D_

6.5 Non-Vascular Stents – Pipeline Products by Regulatory Path_x000D_

6.6 Non-Vascular Stents – Pipeline Products by Estimated Approval Date_x000D_

7 Overview of Key Companies in North America Non-Vascular Stents Market_x000D_

7.1 Boston Scientific Corp_x000D_

7.1.1 Company Overview_x000D_

7.2 Atrium Medical Corp_x000D_

7.2.1 Company Overview_x000D_

7.3 Medtronic Plc_x000D_

7.3.1 Company Overview_x000D_

7.4 Merit Medical Systems Inc_x000D_

7.4.1 Company Overview_x000D_

7.5 Wilson-Cook Medical Inc_x000D_

7.5.1 Company Overview_x000D_

7.6 Cordis Corp_x000D_

7.6.1 Company Overview_x000D_

7.7 W. L. Gore & Associates Inc_x000D_

7.7.1 Company Overview_x000D_

7.8 MITech Co Ltd_x000D_

7.8.1 Company Overview_x000D_

7.9 CR Bard Inc_x000D_

7.9.1 Company Overview_x000D_

7.10 CONMED Corp_x000D_

7.10.1 Company Overview_x000D_

8 Appendix_x000D_

8.1 Research Methodology_x000D_

8.1.1 Coverage_x000D_

8.1.2 Secondary Research_x000D_

8.1.3 Primary Research_x000D_

8.1.4 Market Modeling and Forecasting_x000D_

8.1.5 Company Share Analysis_x000D_

8.1.6 Benchmarking_x000D_

8.2 GlobalData Consulting_x000D_

8.3 Contact Us_x000D_

8.4 Disclaimer

Table

Table 1: Non-Vascular Stents Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Table 2: Non-Vascular Stents Market, North America, Revenue ($m), USD Constant, 2024-2036

Table 3: Non-Vascular Stents Market, North America, Volume (Units), 2024-2036

Table 4: Non-Vascular Stents Market, North America, Volume (Units), 2024-2036

Table 5: Non-Vascular Stents Market, North America, Company Share by Revenue ($m), 2025

Table 6: Non-Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 7: Airway Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 8: Enteral Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 9: Pancreatic and Biliary Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 10: Non-Vascular Stents Market, Canada, Volume (Units), 2024-2036

Table 11: Airway Stents Market, Canada, Volume (Units), 2024-2036

Table 12: Enteral Stents Market, Canada, Volume (Units), 2024-2036

Table 13: Pancreatic and Biliary Stents Market, Canada, Volume (Units), 2024-2036

Table 14: Non-Vascular Stents Market, Canada, Average Price ($), 2024-2036

Table 15: Non-Vascular Stents Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 16: Non-Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 17: Airway Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 18: Enteral Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 19: Pancreatic and Biliary Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 20: Non-Vascular Stents Market, Mexico, Volume (Units), 2024-2036

Table 21: Airway Stents Market, Mexico, Volume (Units), 2024-2036

Table 22: Enteral Stents Market, Mexico, Volume (Units), 2024-2036

Table 23: Pancreatic and Biliary Stents Market, Mexico, Volume (Units), 2024-2036

Table 24: Non-Vascular Stents Market, Mexico, Average Price ($), 2024-2036

Table 25: Non-Vascular Stents Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025

Table 26: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 27: Airway Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 28: Enteral Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 29: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 30: Non-Vascular Stents Market, United States, Volume (Units), 2024-2036

Table 31: Airway Stents Market, United States, Volume (Units), 2024-2036

Table 32: Enteral Stents Market, United States, Volume (Units), 2024-2036

Table 33: Pancreatic and Biliary Stents Market, United States, Volume (Units), 2024-2036

Table 34: Non-Vascular Stents Market, United States, Average Price ($), 2024-2036

Table 35: Non-Vascular Stents Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 36: Non-Vascular Stents Market Pipeline Products

Table 37: Non-Vascular Stents – Pipeline Products by Stage of Development

Table 38: Non-Vascular Stents Companies – Pipeline Products by Stage of Development

Table 39: Non-Vascular Stents – Pipeline Products by Segment

Table 40: Non-Vascular Stents – Pipeline Products by Territory

Table 41: Non-Vascular Stents – Pipeline Products by Regulatory Path

Table 42: Non-Vascular Stents – Pipeline Products by Estimated Approval Date

Table 43: Total Number of Primary Research Participants, General Surgery Devices Market, by Country

Figures

Figure 1: Non-Vascular Stents Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Figure 2: Non-Vascular Stents Market, North America, Revenue ($m), USD Constant, 2024-2036

Figure 3: Non-Vascular Stents Market, North America, Volume (Units), 2024-2036

Figure 4: Non-Vascular Stents Market, North America, Volume (Units), 2024-2036

Figure 5: Non-Vascular Stents Market, North America, Company Share (%), 2025

Figure 6: Non-Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 7: Airway Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 8: Enteral Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 9: Pancreatic and Biliary Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 10: Non-Vascular Stents Market, Canada, Volume (Units), 2024-2036

Figure 11: Airway Stents Market, Canada, Volume (Units), 2024-2036

Figure 12: Enteral Stents Market, Canada, Volume (Units), 2024-2036

Figure 13: Pancreatic and Biliary Stents Market, Canada, Volume (Units), 2024-2036

Figure 14: Non-Vascular Stents Market, Canada, Company Share (%), 2025

Figure 15: Non-Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 16: Airway Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 17: Enteral Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 18: Pancreatic and Biliary Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 19: Non-Vascular Stents Market, Mexico, Volume (Units), 2024-2036

Figure 20: Airway Stents Market, Mexico, Volume (Units), 2024-2036

Figure 21: Enteral Stents Market, Mexico, Volume (Units), 2024-2036

Figure 22: Pancreatic and Biliary Stents Market, Mexico, Volume (Units), 2024-2036

Figure 23: Non-Vascular Stents Market, Mexico, Company Share (%), 2025

Figure 24: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 25: Airway Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 26: Enteral Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 27: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 28: Non-Vascular Stents Market, United States, Volume (Units), 2024-2036

Figure 29: Airway Stents Market, United States, Volume (Units), 2024-2036

Figure 30: Enteral Stents Market, United States, Volume (Units), 2024-2036

Figure 31: Pancreatic and Biliary Stents Market, United States, Volume (Units), 2024-2036

Figure 32: Non-Vascular Stents Market, United States, Company Share (%), 2025

Figure 33: Non-Vascular Stents – Pipeline Products by Stage of Development

Figure 34: Non-Vascular Stents – Pipeline Products by Segment

Figure 35: Non-Vascular Stents – Pipeline Products by Territory

Figure 36: Non-Vascular Stents – Pipeline Products by Regulatory Path

Figure 37: Non-Vascular Stents – Pipeline Products by Estimated Approval Date

North America Non-Vascular Stents Market Outlook to 2036 – Airway Stents, Enteral Stents and Pancreatic and Biliary Stents standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more General Surgery reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Non-Vascular Stents Market Outlook to 2036 – Airway Stents, Enteral Stents and Pancreatic and Biliary Stents in real time.

Access a live North America Non-Vascular Stents Market Outlook to 2036 – Airway Stents, Enteral Stents and Pancreatic and Biliary Stents dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Non-Vascular Stents Market Outlook to 2036 – Airway Stents, Enteral Stents and Pancreatic and Biliary Stents

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports